Healthcare Policy Changes in Osteoporosis Can Improve Outcomes and Reduce Costs in the United States

被引:103
|
作者
Lewiecki, E. Michael [1 ]
Ortendahl, Jesse D. [2 ]
Vanderpuye-Orgle, Jacqueline [3 ]
Grauer, Andreas [3 ]
Arellano, Jorge [3 ]
Lemay, Jeffrey [3 ]
Harmon, Amanda L. [2 ]
Broder, Michael S. [2 ]
Singer, Andrea J. [4 ]
机构
[1] New Mexico Clin Res & Osteoporosis Ctr, Albuquerque, NM USA
[2] Partnership Hlth Analyt Res LLC, Beverly Hills, CA USA
[3] Amgen Inc, Thousand Oaks, CA 91320 USA
[4] MedStar Georgetown Univ Hosp, Washington, DC USA
关键词
OSTEOPOROSIS; FRACTURE PREVENTION; FRACTURE RISK ASSESSMENT; GENERAL POPULATION STUDIES; HEALTH ECONOMICS;
D O I
10.1002/jbm4.10192
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In the United States, osteoporosis affects over 10 million adults, has high societal costs ($22 billion in 2008), and is currently being underdiagnosed and undertreated. Given an aging population, this burden is expected to rise. We projected the fracture burden in US women by modeling the expected demographic shift as well as potential policy changes. With the anticipated population aging and growth, annual fractures are projected to increase from 1.9 million to 3.2 million (68%), from 2018 to 2040, with related costs rising from $57 billion to over $95 billion. Policy-driven expansion of case finding and treatment of at-risk women could lower this burden, preventing 6.1 million fractures over the next 22 years while reducing payer costs by $29 billion and societal costs by $55 billion. Increasing use of osteoporosis-related interventions can reduce fractures and result in substantial cost-savings, a rare and fortunate combination given the current landscape in healthcare policy. (C) 2019 The Authors. JBMR Plus published by Wiley Periodicals, Inc. on behalf of American Society for Bone and Mineral Research.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] MEDICARE POLICY CHANGES TO IMPROVE SURGICAL OUTCOMES
    MERRICK, NJ
    CLINICAL RESEARCH, 1989, 37 (02): : A798 - A798
  • [32] Recent Changes in the Recognition Policy of the United States
    Hill, Norman L.
    AMERICAN POLITICAL SCIENCE REVIEW, 1933, 27 (05) : 841 - 842
  • [33] CHANGES IN THE UNITED-STATES RICE POLICY
    WAILES, E
    ARKANSAS FARM RESEARCH, 1982, 31 (02): : 2 - 2
  • [34] DOES CIDOFOVIR TREATMENT FOR BKVAN REDUCE COSTS AND IMPROVE PATIENT OUTCOMES?
    Hua, D.
    Howard, K.
    Craig, J.
    Chapman, J.
    Wong, G.
    NEPHROLOGY, 2011, 16 : 79 - 79
  • [35] Suicide and Suicidal Attempts in the United States: Costs and Policy Implications
    Shepard, Donald S.
    Gurewich, Deborah
    Lwin, Aung K.
    Reed, Gerald A., Jr.
    Silverman, Morton M.
    SUICIDE AND LIFE-THREATENING BEHAVIOR, 2016, 46 (03) : 352 - 362
  • [36] Can implantable cardioverter-defibrillator therapy reduce healthcare costs? Discussion
    Schlepper
    Hauer
    Rowland
    Klein
    Wever
    AMERICAN JOURNAL OF CARDIOLOGY, 1996, 78 : 138 - 139
  • [37] Can we reduce malaria in pregnancy and improve birth outcomes?
    Kakuru, Abel
    Jagannathan, Prasanna
    LANCET, 2023, 401 (10381): : 973 - 975
  • [38] DIRECT HEALTHCARE COSTS ASSOCIATED WITH PRIMARY SYMPTOMATIC CYTOMEGALOVIRUS IN THE UNITED STATES
    Georgieva, M.
    Wang, J.
    Lu, T.
    Diaz-Decaro, J.
    Kunzweiler, C.
    Hall, S.
    Buck, P.
    VALUE IN HEALTH, 2024, 27 (06) : S70 - S71
  • [39] Healthcare utilization and costs associated with GI cancers in the United States.
    Deng, Aileen
    Mallick, Atrayee Basu
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [40] Healthcare costs and savings associated with increased dairy consumption in the United States
    Scrafford, Carolyn
    Schmier, Jordana K.
    Murphy, Mary M.
    Barraj, Leila M.
    FASEB JOURNAL, 2017, 31